ABL Texcell Diagnostics (formerly ABL Diagnostics) specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
18/09/26	€2.440	-5.43%	5,295
17/09/26	€2.580	+1.57%	2,231
16/09/26	€2.540	0.00%	4,545
15/09/26	€2.540	+4.96%	6,083
14/09/26	€2.420	-3.97%	6,018

Real-time Euronext Paris

More quotes

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris 16:55:00 18/09/2026 BST			5-day change	1st Jan Change
2.440 ^EUR	-5.43%		-3.17%	-18.67%

09-11	ABL Diagnostics Société anonyme proposed to acquire Business operations and assets of IntegraGen SA.	CI
09-11	ABL Diagnostics Offers to Acquire IntegraGen Amid Reorganization Proceedings	MT

Market Cap	39.21M 44.96M 37.02M 33.62M 62.99M 4.31B 63.25M 443M 171M 2.19B 169M 165M 7.06B	P/E 2024	123x	P/E 2025	50x
Enterprise Value	40.14M 46.03M 37.9M 34.42M 64.49M 4.42B 64.76M 454M 175M 2.25B 173M 169M 7.23B	EV / Sales 2024	7,098,474x	EV / Sales 2025	6,185,843x
Free-Float	6.2%	Yield 2024	2.03%	Yield 2025	3.67%

Markets		Quality
Euronext Paris	ABLD	Real-time
CBOE	FAUVp	Real-time
CBOE	0OPO	Real-time
Deutsche Boerse AG	9BK0	Delayed
Börse Stuttgart	9BK0	Delayed

09-11	ABL Diagnostics Société anonyme proposed to acquire Business operations and assets of IntegraGen SA.	CI
09-11	ABL Diagnostics Offers to Acquire IntegraGen Amid Reorganization Proceedings	MT
09-11	Abionyx Pharma Partners With ABL Diagnostics Division for Viral Safety Testing of CER-001	MT
09-10	Abionyx Pharma Enters into Strategic Partnership with TEXCELL (Abl Diagnostics) for Viral Safety and Clearance of Biologics	CI
09-10	ABL Diagnostics partners with Abionyx Pharma
09-08	ABL Diagnostics Maintains Revenue Guidance for the Financial Year 2026	CI
09-08	ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-10	ABL Diagnostics Plans Listing Transfer to Euronext Growth Paris	MT
07-23	French Court OKs ABL Diagnostics' Industrial Plan to Acquire Texcell	MT
07-22	ABL Diagnostics Société anonyme agreed to acquire Assets and Business Operations from Texcell SA for ?0.78 million.	CI
07-02	Abl Diagnostics Société Anonyme Approves Dividend Distribution for Fiscal Year 2025, Payable on July 7, 2026	CI
06-12	Abl Diagnostics Sa and Cdl Pharma Secure Multi-Year International Contract of Up to Eur 2.7 Million Through 2031	CI
06-12	ABL Diagnostics Signs Multi-year Contract to Provide Clinical Trial Services	MT

ABL Texcell Diagnostics Share Price

Stocks

ABLD

FR001400AHX6

Medical Equipment, Supplies & Distribution

Valuation: ABL Texcell Diagnostics

Chart: ABL Texcell Diagnostics

Latest news: ABL Texcell Diagnostics

Press Releases: ABL Texcell Diagnostics

News in other languages: ABL Texcell Diagnostics

Quotes and Performance

Price Extremes

Managers and Directors: ABL Texcell Diagnostics

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

09-17	ABL Diagnostics Becomes ABL Texcell Diagnostics	BU
09-17	ABL Diagnostics Announces Its Participation in Investor Access @ Maison De La Chimie Paris 2026	BU
09-15	ABL Diagnostics to Participate in the European Main MidCap Event Paris 2026 on September 30 and October 1, 2026	BU
09-14	ABL Diagnostics Announces Availability of the Latest All Invest Securities Research Report	BU
09-11	ABL Diagnostics (ABLD) Announces the Filing of a Takeover Bid for Integragen	BU

09-18	ABL TEXCELL DIAGNOSTICS : MODIFICATION DES RESSOURCES ALLOUEES AU CONTRAT DE LIQUIDITE
09-18	Bourse : Solutions 30 et Boiron souffrent, Stellantis pourrait vendre Aramis
09-18	ABL Diagnostics change de nom, mais reste sur le marché réglementé
09-18	Parfois, la bourse aime aussi se faire fouetter
09-17	ABL DIAGNOSTICS DEVIENT ABL TEXCELL DIAGNOSTICS

1 day	-5.43%
1 week	-3.17%
1 month	+3.39%
3 months	-7.58%
6 months	-27.38%
Current year	-18.67%

1 week	2.42	2.68
1 month	2.2	2.78
Current year	2.12	5
1 year	2.12	5
3 years	2.12	9.7
5 years	1.99	26
10 years	1.28	26

Director	Title	Age	Since
Noemie Sadoun CHM	Chairman	-	-
Laure Raffaelli BRD	Director/Board Member	-	-
Deborah Szafir BRD	Director/Board Member	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
28/07/26	Advanced Biological Laboratories SA	Sell	Company	-60,000	0.3723%
20/07/26	Advanced Biological Laboratories SA	Sell	Company	-65,616	0.4072%
06/07/26	Advanced Biological Laboratories SA	Sell	Company	-62,308	0.3867%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABL TEXCELL DIAGNOSTICS	-5.43%	-3.17%	-44.55%	-74.85%	44.96M
ABBOTT LABORATORIES	+0.37%	+0.65%	-24.57%	+1.93%	178B
MEDTRONIC PLC	-0.69%	+1.29%	-3.10%	+11.50%	118B
CENCORA, INC.	-0.20%	-3.98%	+6.47%	+71.79%	58.92B
BECTON, DICKINSON AND COMPANY	-0.24%	+1.74%	-3.26%	-31.97%	49.29B
HOYA CORPORATION	-0.22%	-0.37%	+10.27%	+40.45%	48.17B
DEXCOM, INC.	+1.61%	+7.61%	+32.47%	-5.11%	33.72B
MEDLINE INC.	-1.49%	-2.74%	-	-	27.76B
WEST PHARMACEUTICAL SERVICES, INC.	-1.17%	+4.64%	+42.17%	-7.72%	25.5B
SARTORIUS STEDIM BIOTECH	+1.02%	+5.99%	+6.51%	-15.81%	22.1B
Average	-0.64%	+1.35%	+2.49%	-1.09%	56.09B
Weighted average by Cap.	-0.08%	+1.03%	-3.19%	+10.46%

	2024	2025
Net sales	5.87 6.73 5.54 5.03 9.43 645.87 9.47 66.39 25.62 328.37 25.29 24.72 1.06K	7.97 9.13 7.52 6.83 12.8 876.54 12.85 90.1 34.77 445.65 34.32 33.55 1.43K
Net income	285K 327K 269K 245K 458K 31.38M 460K 3.23M 1.24M 15.95M 1.23M 1.2M 51.33M	987K 1.13M 932K 846K 1.59M 109M 1.59M 11.16M 4.31M 55.2M 4.25M 4.16M 178M
Net Debt	2.02M 2.32M 1.91M 1.74M 3.25M 223M 3.26M 22.89M 8.83M 113M 8.72M 8.52M 364M	933K 1.07M 881K 800K 1.5M 103M 1.5M 10.55M 4.07M 52.18M 4.02M 3.93M 168M